Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Pathology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Drug Deliv Transl Res. 2020 Oct;10(5):1428-1441. doi: 10.1007/s13346-020-00715-6.
Following skin injury, the overproduction of reactive oxygen species (ROS) during the inflammatory phase can cause tissue damage and delay in wound healing. Methylene blue (MB) decreases mitochondrial ROS production and has antioxidant effects. The authors aimed to prepare MB-loaded niosomes using the ultra-sonication technique as a green formulation method. A Box-Behnken design was selected to optimize formulation variables. The emulsifier to cholesterol ratio, HLB of mixed surfactants (Span 60 and Tween 60), and sonication time were selected as independent variables. Vesicle size, zeta potential (ZP), and drug entrapment capacity percentage were studied as dependent variables. The optimized formulation of niosomes showed spherical shape with optimum vesicle size of 147.8 nm, ZP of - 18.0 and entrapment efficiency of 63.27%. FTIR study showed no observable interaction between MB and other ingredients. In vivo efficacy of optimized formulation was evaluated using an excision wound model in male Wistar rat. Superoxide dismutase (SOD, an endogenous antioxidant) and malondialdehyde (MDA, an end product of lipid peroxidation) levels in skin tissue samples were evaluated. After 3 days, MDA was significantly decreased in niosomal gel-treated group, whereas SOD level was increased. Histological results indicate rats that received niosomal MB were treated effectively faster than other ones. Graphical abstract.
皮肤损伤后,炎症期内活性氧(ROS)的过度产生会导致组织损伤和伤口愈合延迟。亚甲蓝(MB)可减少线粒体 ROS 的产生,具有抗氧化作用。作者旨在使用超声技术制备载 MB 的尼莫司汀作为绿色制剂方法。选择 Box-Behnken 设计来优化配方变量。乳化剂与胆固醇的比例、混合表面活性剂(Span 60 和 Tween 60)的 HLB 和超声时间被选为独立变量。作为依赖变量研究了囊泡大小、Zeta 电位(ZP)和药物包封率百分比。尼莫司汀的优化配方显示出球形,最佳囊泡大小为 147.8nm,ZP 为-18.0,包封效率为 63.27%。FTIR 研究表明 MB 与其他成分之间没有观察到相互作用。使用雄性 Wistar 大鼠的切除伤口模型评估优化配方的体内功效。评估皮肤组织样本中的超氧化物歧化酶(SOD,一种内源性抗氧化剂)和丙二醛(MDA,脂质过氧化的终产物)水平。第 3 天,尼莫司汀凝胶处理组 MDA 明显降低,而 SOD 水平升高。组织学结果表明,接受尼莫司汀 MB 治疗的大鼠比其他大鼠更快地得到有效治疗。